PubMed |
Connective tissue disorders: systemic lupus erythematosus, Sjögren’s syndrome, and scleroderma
|
Streifler JY e Molad Y (2014) |
Revisão |
LES, síndrome de Sjögren, esclerose sistêmica, (fisiopatologia, diagnóstico e tratamento) |
PubMed |
Diagnosis andclassificationof central nervous systemvasculitis
|
Hajj-Ali RA e Calabrese LH (2014) |
Revisão |
Vasculite no SNC |
PubMed |
Cervical spine instability in rheumatoid arthritis
|
da Côrte FC e Neves N (2014) |
Revisão |
Comprometimento do SNC |
PubMed |
Update on the use of biologics in vasculitides
|
Vishwanath S, Relan M, Shen L e Ambrus JL Jr. (2014) |
Revisão |
Tratamento |
PubMed |
Neuro-Behçet syndrome
|
Saip S, Akman-Demir G e Siva A (2014) |
Revisão |
Comprometimento do CNS, diagnóstico e tratamento |
PubMed |
Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome
|
Hammad TA e Hajj- Ali RA (2013) |
Revisão |
Comprometimento do SNC |
PubMed |
New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review
|
Matsumoto T, Nakamura I, Miura A, Momoyama G e Ito K (2013) |
Relato de caso e revisão da literatura |
Comprometimento do SNC |
PubMed |
Neurologic involvement inscleroderma: a systematic review
|
Amaral TN, Peres FA, Lapa AT, Marques-Neto JF e Appenzeller S (2013) |
Revisão sistemática |
Comprometimento do SNC e SNP |
PubMed |
Characteristics ofneurologicalmanifestations of Behçet’s disease: a retrospective monocentric study in Tunisia
|
Houman MH, Bellakhal S, Ben Salem T, Hamzaoui A, Braham A, Lamloum M, et al. (2013) |
Retrospectivo |
Comprometimento do SNC |
PubMed |
Neurologicalcomplicationsof Behçet’ssyndrome
|
Kidd D (2012) |
Revisão |
Comprometimento do SNC e tratamentos |
PubMed |
Peripheral neuropathies in Sjögren’s syndrome: a critical update on clinical features and pathogenetic mechanisms
|
Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutsopoulos HM, Tzioufas AG, et al. (2012) |
Revisão |
Comprometimento do SNP |
PubMed |
Addition of infliximab to standard therapy for ANCA-associated vasculitis
|
Morgan MD, Drayson MT, Savage CO e Harper L (2011) |
Coorte |
Tratamento |
PubMed |
Infliximab or rituximab for refractory Wegener’s granulomatosis: long-term follow-up. A prospective randomised multicentre study on 17 patients
|
DeMenthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, et al. (2011) |
Randomizado |
Tratamento |
PubMed |
Churg-Strauss syndrome complicated by neuropathy: a clinicopathological study of nine cases
|
Kararizou E, Davaki P, Spengos K e Dimitracopoulos A (2011) |
Ensaio clínico |
Comprometimento do SNC e SNP |
PubMed |
Neurologicalinvolvement in Wegener’s granulomatosis
|
Holle JU e Gross WL (2011) |
Revisão sistemática |
Comprometimento do SNC e SNP |
PubMed |
Clinical manifestations of neurological involvement in primary Sjögren’s syndrome
|
Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, et al. (2011) |
Coorte |
Comprometimento do SNC e SNP |
PubMed |
Isolated cerebral vasculitis associated with rheumatoid arthritis
|
Caballol Pons N, Montalà N, Valverde J, Brell M, Ferrer I, Martinez-Yélamos S (2010) |
Caso |
Comprometimento do SNC |
PubMed |
Neurologic complications of Churg-Strauss syndrome - a prospective monocentric study
|
Wolf J, Bergner R, Mutallib S, Buggle F e Grau AJ (2010) |
Prospectivo |
Comprometimento do SNP e tratamento |
PubMed |
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients
|
Ribi C, Cohen P, Pagnoux C, Mahr A, Arène JP, Puéchal X, et al. (2010) |
Randomizado |
Tratamento |
PubMed |
The neurologic manifestations of systemic lupus erythematosus
|
Greenberg BM (2009) |
Revisão |
Tratamento |
PubMed |
The involvement of the peripheral nervous system in biopsy proven active giant cell arteritis
|
Pfadenhauer K, Roesler A e Golling A (2007) |
Série de casos |
Comprometimento do SNP |
PubMed |
Infliximab for maintenance of glucocorticosteroid induced remission of giant cell arteritis: a randomized trial
|
Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, et al. (2007) |
Randomizado |
Tratamento |
PubMed |
Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases
|
Kararizou E, Davaki P, Karandreas N, Danou R, Vassilopoulos D (2005) |
Ensaio clínico |
Comprometimento do SNP |
PubMed |
Vasculitis of the nervous system
|
Younger DS (2004) |
Revisão |
Comprometimento do SNP + SNC |
PubMed |
Low dose MTX for progressive neuro-Behçet’s disease. A follow-up study for 4 years
|
Kikuchi H, Aramaki K e Hirohata S (2003) |
Série de casos |
Tratamento |
PubMed |
Neuromuscular complications of connective tissue diseases
|
Rosenbaum R (2001) |
Revisão |
Comprometimento do SNP na AR, síndrome de Sjögren, LES, esclerose sistêmica e vasculite |
PubMed |
Diagnosis and management of isolated angiitis of the central nervous system
|
Moore PM (1989) |
Revisão |
Tratamento |
PubMed |
Isolated benign cerebral vasculitis
|
Bettoni L, Juvarra G, Bortone E e Lenchi A (1984) |
Caso + revisão |
Comprometimento do SNC |